What it sells
Medical AI
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospital radiology and neurology departments (large hospitals on-premise; small hospitals subscribing).
Trigger: what makes them buy now?
MRI waits of 2-3 months at university hospitals, high cost, and scan limits for claustrophobic or metal-implant patients, so hospitals want MRI-level analysis from routine CT.
Workflow: what inputs become what output?
BrainCura auto-segments a CT brain scan into 98 regions, measures volumes vs age norms, produces atrophy/brain-age/Alzheimer-tracking reports and sends results to PACS.
Economics: what it saves and how it charges
Software licence: on-premise installs for large hospitals and SaaS subscription for small hospitals and overseas; targets FDA and CE approval.
Distribution: how it reaches customers
Direct sales to hospitals in Korea first, then global partnerships (SE Asia, US, Japan) after FDA/CE.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-07-16 | Seed | KRW 400M | FuturePlay | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-13.